These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11460016)

  • 1. Polymorphisms of the tissue factor pathway inhibitor gene and the risk of restenosis after coronary angioplasty.
    Moatti D; Meirhaeghe A; Ollivier V; Bauters C; Amouyel P; de Prost D
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):317-23. PubMed ID: 11460016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPI.
    Moatti D; Seknadji P; Galand C; Poirier O; Fumeron F; Desprez S; Garbarz M; Dhermy D; Arveiler D; Evans A; Luc G; Ruidavets JB; Ollivier V; Hakim J; Aumont MC; de Prost D
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):862-9. PubMed ID: 10195910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.
    Humphries S; Bauters C; Meirhaeghe A; Luong L; Bertrand M; Amouyel P
    Eur Heart J; 2002 May; 23(9):721-5. PubMed ID: 11977998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
    Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
    J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
    Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
    Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.
    Wijpkema JS; van Haelst PL; Monraats PS; Bruinenberg M; Zwinderman AH; Zijlstra F; van der Steege G; de Winter RJ; Doevendans PA; Waltenberger J; Jukema JW; Tio RA
    Pharmacogenet Genomics; 2006 May; 16(5):331-7. PubMed ID: 16609364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant.
    Gulesserian T; Wenzel C; Endler G; Sunder-Plassmann R; Marsik C; Mannhalter C; Iordanova N; Gyöngyösi M; Wojta J; Mustafa S; Wagner O; Huber K
    Clin Chem; 2005 Sep; 51(9):1661-5. PubMed ID: 16020495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty.
    Rauchhaus M; Gross M; Schulz S; Francis DP; Greiser P; Norwig A; Weidhase L; Coats AJ; Dietz R; Anker SD; Gläser C
    Int J Cardiol; 2002 Jun; 83(3):249-57. PubMed ID: 12036529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting.
    Koch W; Böttiger C; Mehilli J; von Beckerath N; Neumann FJ; Schömig A; Kastrati A
    Am J Cardiol; 2001 Nov; 88(10):1120-4. PubMed ID: 11703955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting.
    Li P; Elrayess MA; Gomma AH; Palmen J; Hawe E; Fox KM; Humphries SE
    Chin Med J (Engl); 2005 Sep; 118(18):1525-32. PubMed ID: 16232329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty.
    Samani NJ; Martin DS; Brack M; Cullen J; Chauhan A; Lodwick D; Harley A; Swales JD; de Bono DP; Gershlick AH
    Lancet; 1995 Apr; 345(8956):1013-6. PubMed ID: 7723497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new T-287C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels.
    Moatti D; Haidar B; Fumeron F; Gauci L; Boudvillain O; Seknadji P; Olliver V; Aumont MC; de Prost D
    Thromb Haemost; 2000 Aug; 84(2):244-9. PubMed ID: 10959696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The -374T/A variant of the rage gene promoter is associated with clinical restenosis after coronary stent placement.
    Falcone C; Emanuele E; Buzzi MP; Ballerini L; Repetto A; Canosi U; Mazzucchelli I; Schirinzi S; Sbarsi I; Boiocchi C; Cuccia M
    Int J Immunopathol Pharmacol; 2007; 20(4):771-7. PubMed ID: 18179750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population.
    Shim CY; Park S; Yoon SJ; Park HY; Kim HT; Oh B; Park C; Ko YG; Choi D; Jang Y; Chung N
    Cardiology; 2007; 107(4):261-8. PubMed ID: 16954682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
    Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tsuzuki M; Imai H; Kamiya H; Mabuchi Y; Matsui H; Hayakawa T
    Circ J; 2002 Apr; 66(4):311-6. PubMed ID: 11954942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries.
    Yin X; Yutani C; Ikeda Y; Enjyoji K; Ishibashi-Ueda H; Yasuda S; Tsukamoto Y; Nonogi H; Kaneda Y; Kato H
    Cardiovasc Res; 2002 Dec; 56(3):454-63. PubMed ID: 12445886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Gene Polymorphisms/Haplotypes and Plasma Level of TGF-β1 in Susceptibility to In-Stent Restenosis Following Coronary Implantation of Bare Metal Stent in Chinese Han Patients.
    Chen HJ; Mo N; Zhang YF; Su GZ; Wu HD; Pei F
    Int Heart J; 2018 Jan; 59(1):161-169. PubMed ID: 29332922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.
    Erbel R; Haude M; Höpp HW; Franzen D; Rupprecht HJ; Heublein B; Fischer K; de Jaegere P; Serruys P; Rutsch W; Probst P
    N Engl J Med; 1998 Dec; 339(23):1672-8. PubMed ID: 9834304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 cluster genes and occurrence of post-percutaneous transluminal coronary angioplasty restenosis: a prospective, angiography-based evaluation.
    Zee RY; Fernandez-Ortiz A; Macaya C; Pintor E; Fernandez-Cruz A; Lindpaintner K
    Atherosclerosis; 2003 Dec; 171(2):259-64. PubMed ID: 14644395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.